Medicinova, Inc. (MNOV)
Medicinnova, Inc. is a biotechnology company focused on developing novel therapeutics for rare and serious diseases. The company's research primarily targets conditions with limited treatment options, leveraging its expertise in drug discovery and development to bring innovative solutions to unmet medical needs.
Company News
MediciNova completed enrollment for its COMBAT-ALS Phase 2b/3 clinical trial of MN-166, a potential treatment for Amyotrophic Lateral Sclerosis (ALS), marking a significant milestone in neurodegenerative disease research.
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Destiny Tech100 Inc (NASDAQ: DX...
These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.